Pathophysiology
Clonal plasma cells in marrow secrete monoclonal Ig; free light chains cause cast nephropathy; osteoclast activation causes lytic lesions.
Sources: IMWG Diagnostic Criteria (Lancet Oncol 2014;15:e538); NEJM Daratumumab (NEJM 2016;375:1319)
Presentation
Bone pain (vertebral), pathological fractures, fatigue from anaemia, renal failure, hypercalcaemia, infection risk from immunoparesis.
Diagnosis
IMWG: clonal plasma cells >=10% + CRAB or myeloma-defining events. SPEP/UPEP, serum free light chains, low-dose whole-body CT or PET-CT, marrow with FISH.
Management
Induction: bortezomib-lenalidomide-dexamethasone-daratumumab (VRd-D). Autologous stem-cell transplant for eligible. Maintenance lenalidomide. Relapsed: pomalidomide, carfilzomib, isatuximab, CAR-T (idecabtagene, ciltacabtagene) and bispecifics.




